Educate

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Collaborate

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transform

Dedicated to improving the lives of people with diabetes throughout the world by empowering healthcare professionals with training, education and information on diabetes and cardiovascular disease.
Our Mission >>

UPCOMING EVENTS


STAY INFORMED

Sign up for our mailing list to receive access to exclusive resources, newsletters, updates, and notifications of upcoming events.

Your Email*

Your Name*

Your Specialty*
CardiologyDiabetesEndocrinologyInternal Medicine/Primary CareNephrologyNursingOther

Your Country*

Now on Demand


“What’s New in MASLD: A Diagnosis and Management Update for the Busy Clinician” is a one-hour program that addresses the epidemic of Metabolic Dysfunction Associated Liver Disease (MASLD, formerly known as NAFLD). It provides an increased understanding of why MASLD is affecting a significant percentage of people with diabetes, clear direction on early diagnosis that will lead to better patient management, and new treatment options, as well as guidelines that have been proven to be effective. The renowned faculty provide valuable information about the extent to which diabetes increases the risk of MASLD and what the clinician needs to look for.

Click here to view the program and be sure to complete the program evaluation. Your comments are very important to us as we develop future educational initiatives.

This program is sponsored by the Worldwide Initiative for Diabetes Education and supported by an educational grant from Novo Nordisk A/S.



“Harnessing the Power of AI to Help Eliminate Preventable Blindness” was presented live in partnership with the International Diabetes Foundation (IDF) Virtual Congress 2023 last December. It is now available as an on-demand program for continued viewership. This one-hour program, chaired by Prof. Andrew J.M. Boulton from the University of Manchester in Manchester, England, discusses the evolution of eye screening technology, the new science of artificial intelligence (AI) technology, and data regarding AI screening and how it can impact clinical practice. Given that diabetic retinopathy affects approximately 30 percent of persons with diabetes and is one of the most prevalent eye afflictions in existence today, the use of AI technology in eye screening is a significant advancement.

Joining Prof. Boulton in this program are:

  • David Kerr, MB ChB, DM, FRCPE, FRCP
    Sutter Center for Health Systems Research
    Sacramento, CA, USA
  • Jennifer Lim, MD, FARVO
    University of Illinois at Chicago
    Chicago, IL, USA
  • Steven Yeh, MD, FASRS
    University of Nebraska Medical Center
    Omaha, NE, USA
Click here to view the program and be sure to complete the program evaluation. Your comments are very important to us as we develop future educational initiatives.

This program is sponsored by the Worldwide Initiative for Diabetes Education and supported by an unrestricted educational grant from Eyenuk, Inc.